Patients using anti-TNF specialty drugs to treat RA and Crohn’s aren’t aware of treatment choices HealthCore study published in American Health - Specialty drugs - Document - PDFSEARCH.IO

First Page	Meta Content
	Patients using anti-TNF specialty drugs to treat RA and Crohn’s aren’t aware of treatment choices HealthCore study published in American Health & Drug Benefits finds half of all patients don’t discuss options with Add to Reading List Document Date: 2014-05-05 08:45:20 Open Document File Size: 590,82 KB Share Result on Facebook Company anti-TNF / WellPoint Inc. / HealthCore Inc. / / Currency USD / / / IndustryTerm physician provider site / health insurer / pharmacy services / / MedicalCondition chronic inflammatory conditions / rheumatoid arthritis / Crohn’s disease / / MedicalTreatment intravenous infusion / / Person Wilmington / Alex Ruggieri / Andrea DeVries / / / Position physician / medical director for pharmacy services / co-author / director of payer and provider research / / Product Remicade / / ProvinceOrState Delaware / / URL www.healthcore.com / / SocialTag Biology Immunosuppressants Autoimmune diseases Immune system Immunology TNF inhibitor Infliximab Rheumatoid arthritis Health care Medicine

Patients using anti-TNF specialty drugs to treat RA and Crohn’s aren’t aware of treatment choices HealthCore study published in American Health & Drug Benefits finds half of all patients don’t discuss options with Add to Reading List